Bought
Maintained
Sold
Other funds holding CCJ
UBS AM's CCJ Position: Q2 2026 in Review
UBS AM reduced its Cameco (CCJ) stake by 0.95% in Q2 2026, selling an estimated $6.84K and leaving 6,393 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.
UBS AM first reported a position in CCJ in Q1 2018 and has held it in 15 quarters since. The position peaked at $56.4M in Q2 2025. 1,033 funds tracked by Wall St. Rank hold CCJ as of Q2 2026.
- UBS AM held 6,393 shares of Cameco worth $651K as of Q2 2026.
- UBS AM sold 61 Cameco shares in Q2 2026, an estimated $6.84K.
- Cameco made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2471 holding.
- UBS AM first reported a position in Cameco in Q1 2018 and has held it in 15 quarters since.
- UBS AM's Cameco position peaked at $56.4M in Q2 2025.
- 1,033 funds tracked by Wall St. Rank held Cameco as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.